The 20th edition of BioAsia – The Marquee Healthcare and Life Sciences event, organized by the Government of Telangana, has announced that the coveted Genome Valley Excellence Award for the year 2023 will be conferred upon Prof. Robert S. Langer, in light of his pioneering research that has led to the development of the first commercial mRNA vaccines used for a variety of infectious diseases. Langer is currently the David H. Koch Institute Professor at Massachusetts Institute of Technology (MIT), USA. He is also being acknowledged for his exemplary research in human health, including the detection, monitoring, and treatment of cancer. A veteran in his field, his remarkable contributions to biomedical and therapeutic research include developing long-term and controlled-release drug delivery systems used for a variety of applications including cancer therapy, insulin, and vaccines.
Related Posts
LG Begins Rollout of 2023 Soundbar Lineup in India
BENGALURU, FEBRUARY 24, 2023 — LG Electronics India announced the rollout of the 2023 LG Soundbar lineup, delivering a range…
India Shelter Partners with Impact Guru Foundation to Launch Health Checkup Van
Mumbai, 4th April 2024: India Shelter, a pioneer in affordable housing finance, is proud to announce the launch of its…
Andhra Pradesh government to host an investment drive in Bengaluru.
Bengaluru, 13th February 2023: Close on the heels of its successful Global Investors Summit Curtain raiser event held in New…